A carregar...
Will the potential of peroxisome proliferator‐activated receptor agonists be realized in the clinical setting?
Drugs targeting both peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ) agonists (the thiazolidinediones) and PPAR‐α (the fibrates) have already been developed for clinical use. However, the thiazolidinediones, currently prescribed to treat hyperglycemia and improve peripheral insulin resista...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654069/ https://ncbi.nlm.nih.gov/pubmed/15470905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960271603 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|